This is a prospective case series study To identify potential new urine markers for the diagnosis, risk stratification and prognosis prediction for prostate cancer.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
1. Adult male patients with age \> 18 years old
2. Subject has elevated serum PSA level above 4ng/ml
3. Clinical planned for prostatic biopsy.
You may not be if
1. Patient with recent urinary tract infection within 6 weeks prior to PSA testing and urine collection.
2. Patient with recent urethral instrumentation, such as Foley catheter insertion, cystoscopy etc, within 6 weeks prior to PSA testing and urine collection.
3. Patient with consumption of 5 alpha reductase inhibitors in past 6 months.
4. Patient did not receive any surgery for prostatic pathology
5. Patient refused or unable to provide consent for the study
Clareo Health | To Identify Potential New Urine Markers for the Screening of Prostate Cancer
